ARTICLE | Company News
Texas Biotech files for Canadian approval
May 15, 2000 7:00 AM UTC
TXB filed for approval of its argatroban synthetic thrombin inhibitor to treat heparin-induced thrombocytopenia (HIT). The submission has priority review in Canada. ...